Delivery Order SPE2DB24D2109-SPE2DB24FHWBM

Award Date 8/23/24
Potential Completion Date 8/26/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract has a ceiling value of $15,732.57 and a completion date of February 6, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract, valued at $9,589.49, has an ultimate completion date of August 8, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Carvedilol ER 80 mg capsules. The contract has a ceiling value of $14,091.66 and a completion date of December 12, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Carvedilol ER 80 mg capsules, a cardiovascular medication, with a total ceiling value of $11,776.99 and a completion date of January 8, 2024. The contract is a firm-fixed price type and is not associated with any set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 10 mg capsules. The contract has a ceiling value of $8,166.83 and an ultimate completion date of May 5, 2025. The contract is not set-aside and is an open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Carvedilol ER 80 mg capsules, a cardiovascular medication, with a ceiling value of $8,499.68 and a period of performance through October 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,980.77, is for the delivery of Carvedilol ER 40 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 10 mg capsules. The contract has a ceiling value of $11,260.56 and a performance period extending through May 6, 2025. It is a firm-fixed-price contract, indicating a predetermined cost for the ordered items. The contract is not designated as a set-aside, meaning it was open to general competition. As a large pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the supply of Carvedilol ER 20 mg capsules in 30-count packages. The award has a ceiling value of $2,014.80 and a period of performance through June 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,338.87 firm fixed price contract is for the delivery of Carvedilol ER 40 mg capsules. The contract has a performance period extending until June 10, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB24FHWBM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules. The contract has a ceiling value of $12,032.10 and is a firm fixed-price delivery order with an ultimate completion date of August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its ongoing role as a supplier of essential medical commodities to the U.S. federal government, particularly the military healthcare system. The company holds several Indefinite Delivery Contracts (IDCs) with agencies such as the DLA and the Department of Justice, which serve as primary vehicles for providing a wide range of pharmaceutical and medical products to support the healthcare needs of federal beneficiaries. This specific award does not have a set-aside designation.

Generated 11/22/24, 9:42 AM